Transarterial therapies for hepatocellular carcinoma

Author： Sangro Bruno   D'Avola Delia   Iññarrairaegui Mercedes   Prieto Jesus  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.7, 2011-05, pp. : 1057-1073

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic therapies for hepatocellular carcinoma

By Palmer Daniel H   Hussain Syed A   Johnson Philip J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 12, 2004-12 ,pp. : 1555-1568

Informa Healthcare

Access to resources Recommend Favorite

Targeted Therapies in Hepatocellular Carcinoma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-03 ,pp. : 966-974

Bentham Science Publishers

Access to resources Recommend Favorite

Liver-Directed Therapies for Hepatocellular Carcinoma

By Arciero Cletus A.   Sigurdson Elin R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 8, 2006-09 ,pp. : 768-774

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score‐based weighting

By  

Journal of Digestive Diseases, Vol. 16, Iss. 3, 2015-03 ,pp. : 143-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Killer Consequence of Liver Disease: Market Demands New Therapies for Hepatocellular Carcinoma

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 2, 2005-01 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite